🇺🇸 FDA
Pipeline program

Relacorilant with nab-paclitaxel

CORT125134-550

Phase 2 small_molecule completed

Quick answer

Relacorilant with nab-paclitaxel for Solid Tumors is a Phase 2 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CORCEPT THERAPEUTICS INC
Indication
Solid Tumors
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials